Glucagon-like peptide 1 receptor agonists may decrease rates of inflammatory bowel disease flares
1. The use of glucagon-like peptide 1 (GLP-1) agonists in patients with inflammatory bowel disease (IBD) was associated with few ...
Tag: Crohn’s Disease
Sarcopenia is a risk factor for postoperative complications in adults with inflammatory bowel disease
1. Sarcopenia is associated with an increased risk of adverse postoperative outcomes in older adults with inflammatory bowel disease (IBD). ...
Double-balloon enteroscopy for the evaluation of symptomatic small bowel stricture in Crohn’s disease
1. Double-balloon enteroscopy (DBE) has a high diagnostic yield for small-bowel strictures in Crohn’s disease (CD) patients, with no difference ...
Disease activity may be associated with sleep quality in pediatric patients with inflammatory bowel disease
1. In this retrospective study, it was found that inflammatory bowel disease (IBD) activity was associated with poorer sleep scores ...
Wellness Check: Sleep
Digital cognitive behavioral therapy improves insomnia symptoms in stroke survivors 1. In this randomized controlled trial, patients who received digital ...
Upadacitinib therapy effective at inducing remission in Crohn’s disease
1. In this randomized controlled trial, upadacitinib resulted in higher remission rates for patients with Crohn’s disease compared to a ...
Etrasimod improves clinical remission rates in patients with moderate-severe ulcerative colitis
1. In both ELEVATE UC 12 and ELEVATE UC 52, significantly greater patients in the etrasimod group achieved clinical remission ...
Individuals with autoimmune diseases may have an increased risk for cardiovascular diseases
1. An increased incidence of new cardiovascular disease was seen in individuals with autoimmune disease compared to those without. 2. ...
![The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/05/web-cover-classics-with-logo-medicine-BW-small-jpg-350x250.jpg){kind=logo}
MRI offers an alternative to endoscopic assessment of disease activity and severity in ileocolonic Crohn’s disease [Classics Series]
This study summary is an excerpt from the book 2 Minute Medicine's The Classics in Medicine: Summaries of the Landmark ...
Ustekinumab and adalimumab comparable in safety and efficacy for treatment of Crohn’s disease
1. Clinical remission at 52 weeks was similar between ustekinumab and adalimumab. 2. Patient-reported outcomes of stool frequency and abdominal ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
